Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda - Merck & Co (NYSE:MRK)
Pharmaceutical company Merck & Company (NYSE: MRK) reports second quarter financial results before market open Tuesday.
Source: benzinga.com